Search research articles
Contact Us
Filters
Showing results (181-190 of 247) with videos related to
Page
of 25
Sort By:
Journal for Immunotherapy of Cancer
|
March 13, 2026
Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer
Francois Ghiringhelli, Richard Kim, Teresa Macarulla, et al.
Journal of Immunotherapy and Precision Oncology
|
February 8, 2023
Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer
Ji Son, Heather Y Lin, Siqing Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2021
High <i>FGFR1-4</i> mRNA Expression Levels Correlate with Response to Selective FGFR Inhibitors in Breast Cancer
Mònica Sánchez-Guixé, Cinta Hierro, José Jiménez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2014
A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma
Yaping Shou, Douglas M Robinson, Dereck D Amakye, et al.
Emerging Microbes & Infections
|
November 29, 2021
Experimental and field investigations of exposure, replication and transmission of SARS-CoV-2 in pigs in the Netherlands
Reina S Sikkema, Tijs Tobias, Nadia Oreshkova, et al.
Journal of Immunotherapy and Precision Oncology
|
February 17, 2025
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial
Mirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
Cancer Medicine
|
February 13, 2025
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma
Omar Alhalabi, Mohamed A Gouda, Denái R Milton, et al.
Breast Cancer Research : BCR
|
November 3, 2020
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Ana C Garrido-Castro, Cristina Saura, Romualdo Barroso-Sousa, et al.
Viruses
|
July 2, 2021
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals
Benjamin Trinité, Edwards Pradenas, Silvia Marfil, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 28, 2024
Plitidepsin as an Immunomodulator against Respiratory Viral Infections
Alejandro Losada, Nuria Izquierdo-Useros, Pablo Aviles, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 247) with videos related to
Sort By:
Page
of 25
Journal for Immunotherapy of Cancer
|
March 13, 2026
Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer
Francois Ghiringhelli, Richard Kim, Teresa Macarulla, et al.
Journal of Immunotherapy and Precision Oncology
|
February 8, 2023
Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer
Ji Son, Heather Y Lin, Siqing Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2021
High <i>FGFR1-4</i> mRNA Expression Levels Correlate with Response to Selective FGFR Inhibitors in Breast Cancer
Mònica Sánchez-Guixé, Cinta Hierro, José Jiménez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2014
A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma
Yaping Shou, Douglas M Robinson, Dereck D Amakye, et al.
Emerging Microbes & Infections
|
November 29, 2021
Experimental and field investigations of exposure, replication and transmission of SARS-CoV-2 in pigs in the Netherlands
Reina S Sikkema, Tijs Tobias, Nadia Oreshkova, et al.
Journal of Immunotherapy and Precision Oncology
|
February 17, 2025
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial
Mirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
Cancer Medicine
|
February 13, 2025
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma
Omar Alhalabi, Mohamed A Gouda, Denái R Milton, et al.
Breast Cancer Research : BCR
|
November 3, 2020
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Ana C Garrido-Castro, Cristina Saura, Romualdo Barroso-Sousa, et al.
Viruses
|
July 2, 2021
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals
Benjamin Trinité, Edwards Pradenas, Silvia Marfil, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 28, 2024
Plitidepsin as an Immunomodulator against Respiratory Viral Infections
Alejandro Losada, Nuria Izquierdo-Useros, Pablo Aviles, et al.
Page
of 25